David Eisel
Impact in
- Immunology top 10%
- Immune cells in cancer
- Psoriasis: Treatment and Pathogenesis
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immune Response and Inflammation
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Dermatology top 10%
- Dermatology and Skin Diseases
Papers in
- Immunology 10
- Immunotherapy and Immune Responses 4
- Immune cells in cancer 3
- Phagocytosis and Immune Regulation 2
-
- RNA Interference and Gene Delivery 2
- Circular RNAs in diseases 2
- Co-authors
- Stefan B. Eichmüller (8 shared papers)Wolfram Osen (8 shared papers)Rainer König (4 shared papers)Elke Dickes (2 shared papers)Nathan K. Archer (1 shared paper)Thomas Knorpp (1 shared paper)Hubert Kalbacher (1 shared paper)Markus Löffler (1 shared paper)
- Journals
- Oncotarget (2 papers)Cancer Immunology Research (2 papers)Nature Communications (1 paper)PLoS ONE (1 paper)PLoS Computational Biology (1 paper)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
David Eisel
14 papers receiving 406 citations
Peers
Comparison fields: 5 of 59
- Immunology 256
- Dermatology 34
- Microbiology 23
- Cancer Research 52
- Oncology 76
Countries citing papers authored by David Eisel
This map shows the geographic impact of David Eisel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Eisel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Eisel more than expected).
Fields of papers citing papers by David Eisel
This network shows the impact of papers produced by David Eisel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Eisel. The network helps show where David Eisel may publish in the future.
Co-authors
The 25 scholars most cited alongside David Eisel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 200 | |
| 2 | 2019 | 57 | |
| 3 | 2020 | 45 | |
| 4 | 2018 | 28 | |
| 5 | 2018 | 22 | |
| 6 | 2017 | 17 | |
| 7 | 2013 | 16 | |
| 8 | 2020 | 12 | |
| 9 | 2024 | 3 | |
| 10 | 2019 | 2 | |
| 11 | 2020 | 2 | |
| 12 | 2019 | 1 | |
| 13 | 1997 | 1 | |
| 14 | Fre-2, a locus closely linked to Fv-2, is rearranged in some erythroleukemias induced by Friend murine leukemia virus. | 1997 | 1 |
About David Eisel
David Eisel is a scholar working on Immunology, Molecular Biology, Oncology, Cancer Research and Genetics, having authored 14 papers that have together received 407 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Immune cells in cancer (3 papers), CAR-T cell therapy research (3 papers), RNA Interference and Gene Delivery (2 papers), Circular RNAs in diseases (2 papers), MicroRNA in disease regulation (2 papers) and Phagocytosis and Immune Regulation (2 papers). The work is most often cited by research in Immunology (256 citations), Dermatology (34 citations), Microbiology (23 citations), Cancer Research (52 citations) and Oncology (76 citations). David Eisel has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Stefan B. Eichmüller, Wolfram Osen, Rainer König, Elke Dickes, Nathan K. Archer, Thomas Knorpp, Hubert Kalbacher, Markus Löffler, Kamran Ghoreschi and Tim Vierbuchen. Their work appears in journals such as Oncotarget, Cancer Immunology Research, Nature Communications, PLoS ONE and PLoS Computational Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.